We performed a planned secondary analysis comparing viral load suppression ( HIV-@ RNA @ copies/ml ) , safety , and HIV transmission to infants in a trial designed to test the hypothesis that lopinavir/ritonavir versus efavirenz-based ART would reduce placental malaria ( PROMOTE , ClinicalTrials.gov , NCT@ ) .